Scholarlink

Rationale <p>Anxiety is a chronic severe psychiatric disorder. In a series of studies, the implication of the gaseous molecule nitric oxide (NO) in anxiety has been evidenced. Further, the outcome of preclinical research suggests that different NO donors, including sodium nitroprusside (SNP), have expressed an anxiolytic profile revealed in animal models of anxiety. Regardless of this, it is not yet clarified the mechanism(s) of action by which SNP induces its beneficial effects on anxiety. In this context, it has been hypothesized that these effects might be attributed to a potential interaction of this NO donor with the GABA type A and the 5-HT<sub>1A</sub> serotonergic receptors.</p> Objectives <p>The current study was designed to investigate this issue in the male rat.</p> Methods <p>To this end, the light/dark box and the open field tests were utilized.</p> Results <p>SNP (1&#xa0;mg/kg, i.p.) applied acutely induced an anti-anxiety-like effect evidenced either in the light/dark box or in the open field test. Either the GABA<sub>A</sub> receptor antagonist flumazenil (10&#xa0;mg/kg, i.p.) or the 5-HT<sub>1A</sub> serotonin receptor agonist 8-OH-DPAT (0.25&#xa0;mg/kg, i.p.) suppressed the above reported anxiolytic effects of SNP.</p> Conclusions <p>The results here reported propose a functional interaction between SNP with the GABAergic and the serotonergic systems on anxiety and thus, might offer a plausible explanation for SNP’s anxiolytic effects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Involvement of the GABAergic and the serotonergic systems in the anxiolytic effects expressed by the nitric oxide (NO) donor sodium nitroprusside (SNP) in the male rat

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月18日

查看全文
  • Maria Anastasia Parlantza,
  • Nikolaos Pitsikas

摘要

Rationale

Anxiety is a chronic severe psychiatric disorder. In a series of studies, the implication of the gaseous molecule nitric oxide (NO) in anxiety has been evidenced. Further, the outcome of preclinical research suggests that different NO donors, including sodium nitroprusside (SNP), have expressed an anxiolytic profile revealed in animal models of anxiety. Regardless of this, it is not yet clarified the mechanism(s) of action by which SNP induces its beneficial effects on anxiety. In this context, it has been hypothesized that these effects might be attributed to a potential interaction of this NO donor with the GABA type A and the 5-HT1A serotonergic receptors.

Objectives

The current study was designed to investigate this issue in the male rat.

Methods

To this end, the light/dark box and the open field tests were utilized.

Results

SNP (1 mg/kg, i.p.) applied acutely induced an anti-anxiety-like effect evidenced either in the light/dark box or in the open field test. Either the GABAA receptor antagonist flumazenil (10 mg/kg, i.p.) or the 5-HT1A serotonin receptor agonist 8-OH-DPAT (0.25 mg/kg, i.p.) suppressed the above reported anxiolytic effects of SNP.

Conclusions

The results here reported propose a functional interaction between SNP with the GABAergic and the serotonergic systems on anxiety and thus, might offer a plausible explanation for SNP’s anxiolytic effects.